JGS Group is a U.S.-based consulting firm that specialises in helping international medical device, diagnostic, digital health, and biotech companies successfully enter and grow in the U.S. market. We provide integrated expertise across regulatory strategy, reimbursement planning, clinical evidence development, and distribution partnering. Unlike firms that treat these areas separately, JGS applies a holistic commercialisation approach, recognising that regulatory approval, payer acceptance, and market adoption must advance together for success. By addressing these elements simultaneously, we accelerate U.S. market access and reduce the risk of costly delays. Since 2000, JGS has developed customised commercialisation plans for innovative start-ups worldwide, tailoring each strategy to the company’s stage of development, technology profile, and business objectives. Our mission is to act as a trusted partner for international innovators, ensuring their products not only gain FDA clearance but also achieve real-world adoption and impact in the U.S. healthcare system.